PMS43 GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS- POOLED RESULTS FROMTHREE PHASE 3 STUDIES
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66813-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66813-1/fulltext
Section Title :
Section Order :
648
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66813-1&doi=10.1016/S1098-3015(10)66813-1